English
Specials
    Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessGland Pharma Q1 PAT may dip 14.6% YoY to Rs 195.8 cr: Nirmal Bang

    Gland Pharma Q1 PAT may dip 14.6% YoY to Rs 195.8 cr: Nirmal Bang

    Net Sales are expected to increase by 40.3 percent Y-o-Y (up 53.1 percent Q-o-Q) to Rs 1,210.9 crore, according to Nirmal Bang.

    Broker Research
    July 12, 2023 / 12:25 IST
    Gland Pharma

    Gland Pharma

     
     
    live
    • bselive
    • nselive
    Volume
    Todays L/H
    More

    Nirmal Bang has come out with its first quarter (April - June’ 24) earnings estimates for the Pharmaceutical sector. The brokerage house expects Gland Pharma to report net profit at Rs 195.8 crore down 14.6% year-on-year (up 44.9% quarter-on-quarter).

    Net Sales are expected to increase by 40.3 percent Y-o-Y (up 53.1 percent Q-o-Q) to Rs 1,210.9 crore, according to Nirmal Bang.

    Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 2.6 percent Y-o-Y (up 64.5 percent Q-o-Q) to Rs 277 crore.

    Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

    Nirmal Bang_Pharmaceutical

    Broker Research
    first published: Jul 12, 2023 12:24 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347